Key result
A 1-U decrease in response to activated protein C was associated with an increased risk of carotid stenosis, femoral artery stenosis, and prevalent cardiovascular disease.
Why the study?
Does poor response to activated protein C predict advanced atherosclerosis and arterial disease in the general population?
Cross-Sectional (n=826)
Does poor response to activated protein C predict advanced atherosclerosis and arterial disease in the general population?
Poor response to activated protein C is independently associated with advanced atherosclerosis and prevalent cardiovascular disease, regardless of factor V Leiden mutation status.
Answers are grounded in this paper and cite their sources.
May support APC resistance as atherosclerosis biomarker; leaves open prospective validation before clinical use.
BACKGROUND: The potential role of activated protein C (APC) resistance in arterial thrombosis and disease is a matter of ongoing controversy. METHODS AND RESULTS: In the present population-based survey, a random sample of 826 men and women underwent high-resolution duplex ultrasound scanning of the carotid and femoral arteries. Response to APC was expressed in APC ratios. Subjects were tested for the factor V Leiden mutation. The risk of carotid stenosis increased gradually with decreasing response to APC (adjusted OR [95% CI] for a 1-U decrease of response to APC, 1.6 [1. 2 to 2.2]), as did the risk of femoral artery stenosis (1.7 [1.3 to 2.3]) and prevalent cardiovascular disease (1.4 [1.1 to 2.0]). The association between low APC ratio and atherosclerotic vascular disease applied equally to subjects with the factor V Leiden mutation and those without. Our study identified various nongenetic determinants of poor response to APC in the general population, including behavioral, hormonal, and environmental factors. CONCLUSIONS: The present study revealed an independent and gradual association between low response to APC and both advanced atherosclerosis (stenosis) and arterial disease. Resistance to APC due to factor V Leiden mutation was only one facet of this relationship.
No takes yet. Share an insight, caveat, or question.
Kiechl et al. (1999) conducted a cross-sectional in Atherosclerosis and arterial disease (n=826). Decreasing response to activated protein C (APC) was evaluated on Carotid stenosis (OR 1.6, 95% CI 1.2-2.2). A 1-U decrease in response to activated protein C was associated with an increased risk of carotid stenosis, femoral artery stenosis, and prevalent cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: